Biofrontera Inc. Accounts Payable and Other Accrued Liabilities, Current
Biofrontera Inc. (BFRI) had Accounts Payable and Other Accrued Liabilities, Current of $4.71 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes › Payables and Accruals
us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Accounts Payable and Other Accrued Liabilities, Current $4.71M.
- 2026-03-31: Accounts Payable and Other Accrued Liabilities, Current $5.47M.
- 2025-12-31: Accounts Payable and Other Accrued Liabilities, Current $4.90M.
- 2025-09-30: Accounts Payable and Other Accrued Liabilities, Current $6.55M.
| Period end | Accounts Payable and Other Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $4.71M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $5.47M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $4.90M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $6.55M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $5.81M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $4.58M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.27M 10-K · filed 2026-03-19 |
| 2024-09-30 | $4.66M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $3.59M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $4.23M 10-Q · filed 2024-05-15 |
| 2023-12-31 | $4.49M 10-K · filed 2025-03-20 |
| 2023-09-30 | $11.04M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $10.74M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $11.13M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $10.86M 10-K · filed 2024-03-15 |
| 2022-09-30 | $9.44M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $9.41M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $8.55M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $9.65M 8-K · filed 2023-10-03 |
| 2021-09-30 | $9.26M 10-Q · filed 2021-11-30 |
| 2020-12-31 | $2.71M 10-K · filed 2022-04-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B |